AbstractBackgroundHbA1c is recommended for monitoring glycaemic control in people with cystic fibrosis-related diabetes (CFRD). However the relationship between HbA1c and mean plasma glucose concentration (MPG) has not been established in CFRD, as in other forms of diabetes mellitus.Methods20 people (13 male, 29.7±8.8 years, 10 CFRD) with cystic fibrosis (CF) underwent HbA1c measurement and 48 h continuous glucose monitoring for estimation of MPG. The relationship between HbA1c and MPG was established and compared to the reported relationship for type 1 diabetes.ResultsHbA1c was strongly correlated with MPG (R2=0.888, p<0.0001) in CF. The relationship of MPG to HbA1c was described by the equation MPG=(1.47×HbA1c)−1.15, giving a 1.47 mmol L−...
Aims To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related di...
BACKGROUND: Cystic fibrosis related diabetes (CFRD) is associated with increased morbidity in CF. Va...
Aims Optimum therapy for patients with diabetes depends on both acute and long-term changes in plasm...
AbstractBackgroundHbA1c is recommended for monitoring glycaemic control in people with cystic fibros...
Context: The clinical utility and implications of continuous glucose monitoring (CGM) in cystic fibr...
BACKGROUND: Cystic fibrosis (CF) leads to pancreatic endocrine dysfunction with progressive glycemic...
BackgroundCystic fibrosis (CF) leads to pancreatic endocrine dysfunction with progressive glycemic d...
Aims To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related di...
Aims To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related di...
AbstractBackgroundAbnormal glucose tolerance is a frequent co-morbidity in cystic fibrosis patients ...
OBJECTIVE — Progressive-cell loss causes catabolism in cystic fibrosis. Existing diagnostic criteria...
Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated wi...
Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated wi...
OBJECTIVE Diabetes is common in cystic fibrosis and increases the risk of death, yet the role of hyp...
BACKGROUND: Cystic fibrosis (CF)-related diabetes is a leading complication of CF and is associated ...
Aims To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related di...
BACKGROUND: Cystic fibrosis related diabetes (CFRD) is associated with increased morbidity in CF. Va...
Aims Optimum therapy for patients with diabetes depends on both acute and long-term changes in plasm...
AbstractBackgroundHbA1c is recommended for monitoring glycaemic control in people with cystic fibros...
Context: The clinical utility and implications of continuous glucose monitoring (CGM) in cystic fibr...
BACKGROUND: Cystic fibrosis (CF) leads to pancreatic endocrine dysfunction with progressive glycemic...
BackgroundCystic fibrosis (CF) leads to pancreatic endocrine dysfunction with progressive glycemic d...
Aims To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related di...
Aims To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related di...
AbstractBackgroundAbnormal glucose tolerance is a frequent co-morbidity in cystic fibrosis patients ...
OBJECTIVE — Progressive-cell loss causes catabolism in cystic fibrosis. Existing diagnostic criteria...
Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated wi...
Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated wi...
OBJECTIVE Diabetes is common in cystic fibrosis and increases the risk of death, yet the role of hyp...
BACKGROUND: Cystic fibrosis (CF)-related diabetes is a leading complication of CF and is associated ...
Aims To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related di...
BACKGROUND: Cystic fibrosis related diabetes (CFRD) is associated with increased morbidity in CF. Va...
Aims Optimum therapy for patients with diabetes depends on both acute and long-term changes in plasm...